Airway Management Devices Market Size, Share, Growth & COVID-19 Impact Analysis, By Type (Infraglottic devices [Endotracheal Tubes and Tracheostomy Tubes], Supraglottic Devices [Oropharyngeal Airways (OPAS), Laryngeal Mask Airways (LMAS), and Nasopharyngeal Airways], Laryngoscopes, and Others), By Application (Anesthesia, Emergency Medicine, and Others), By End User (Hospitals & Ambulatory Surgical Centers, Homecare, and Others), and Regional Forecasts, 2022-2029

The airway management devices market size was valued at USD 1.81 billion in 2021 and is projected to grow from USD 1.89 billion in 2022 to USD 2.55 billion by 2029, exhibiting a CAGR of 4.4% during 2022-2029. North America dominated the global market with a share of 48.06% in 2021.

The global COVID-19 pandemic has been unprecedented and staggering, with airway management devices experiencing lower than anticipated demand across all regions compared to pre-pandemic levels. Based on our analysis, the market exhibited a decline of 7.2% in 2020 as compared to 2019.

The prevalence of chronic diseases such as chronic obstructive pulmonary disease (COPD), cancer, chronic lung diseases, and others is rising due to increased physiological risk factors amongst the population, such as changes in lifestyle, physical inactivity, poor nutrition, and habitual factors such as tobacco and excessive alcohol use. Moreover, the mortality rate among the patient population globally is increasing due to these diseases and other chronic conditions.

• According to an article published by the NCBI in March 2022, chronic obstructive pulmonary disease (COPD) has a worldwide prevalence of 10.1% in population aged 40 years or older.


• According to data revealed by American Lung Association, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD, chronic bronchitis, or emphysema. Moreover, as per similar estimates 148,512 deaths by COPD were reported in the U.S.

Furthermore, the growing prevalence of chronic diseases among the population has emphasized emergency and intensive care admission globally for better treatment of adverse conditions. Thus, the number of patients visiting hospitals in emergency care units has also increased in need for timely treatment.

• According to the Centers for Disease Control and Prevention (CDC), in 2022, 16.2 million emergency department visits resulted in hospital admissions in the U.S. and 2.3 million emergency department visits in admission to critical care.

Such an increase in emergency and inpatient admissions of chronic disorders led to rise in surgical procedures across the globe, further boosting the demand and usage of airway management devices in healthcare centers. Also, the high use of airway devices with the increasing number of anesthetic procedures for surgical interventions in patients globally is expected to drive the airway management devices market growth.

COVID-19 IMPACT

Decline in Routine Elective Surgeries amid Pandemic Affected Market Growth

The impact of the COVID-19 pandemic resulted in a decline in the market growth in 2020. Several countries across the globe faced challenges in accessing medical care and treatment due to postponements & de-prioritization of non-essential surgeries. Also, the disruption caused by the COVID-19 pandemic to international supply chains led to high-profile shortages of critical medical devices.

• For instance, according to an article published by the Centers for Disease Control and Prevention (CDC), in 2021, the U.S. emergency department (ED) visits declined by 42.0% from March 29 - April 25, 2020, after the declaration of a national emergency for COVID-19 pandemic. As per similar estimates, ED visits from December 2020 to January 2021 were 25.0% lower than during the same months in 2019.

Also, during the pandemic, a decline in global anesthetic procedures was reported owing to a decrease in the conduction of elective surgeries, leading to limited adoption of medical devices for airway management in anesthesia, further hampering the market.

• According to a cohort study published by the British Journal of Anesthesia (BJA) in January 2021, between March 16 and May 31, 2021, the median per-week reduction in case volume relative to the same weeks in 2019 in the U.S. hospitals was 57.0%.


• According to a quantitative study conducted in a Hospital in Ireland by BJA in March 2022, the number of cases undertaken by anesthetic trainees from January 2020 to January 2021 decreased by 23.8% compared to the previous year.

However, pending elective surgeries rebounded quickly after the initial COVID-19 shutdown, and inpatient volumes increased across the globe. These led to increased demand and usage of these devices in anesthetic and surgical procedures, further propelling the market.

• According to an article published by Stanford Medicine, in December 2021, post-COVID-19 pandemic, the U.S. hospitals ramped up surgical operations with improved safety protocols, and surgery rates returned to their 2019 levels. Also, by the end of 2020, the total volume of surgeries was only 10.0% below the 2019 volume.

Moreover, the emphasis of key players on manufacturing and product launches of single-use management devices, such as endotracheal tubes, and tracheostomy tubes, over a large application area increased in the healthcare industry. Similarly, amid the COVID-19 pandemic, these devices offered value-based care services such as sterilization & non-containment to patients boosting the use of single-use devices, further reducing the spread of infection.

• In July 2020, NIHON KOHDEN CORPORATION., a U.S. market leader in precision medical products and services, announced launch of NK AWS-S200 video laryngoscope as part of its critical care portfolio. Designed for the safe and secure intubation of patients in even the most difficult situations, the NK AWS-S200 reduced the exposure to aerosolized particles ii, which helped clinicians while intubating patients suffering from COVID-19 or other respiratory infections.

Thus, the rebound in elective surgical cases post-pandemic, coupled with the high adoption of single-use airway devices boosted the market growth.

LATEST TRENDS

Request a Free sample to learn more about this report.

High Adoption of Airway Management Devices in Neonates to Pose Opportunities for Market Development

A continuous upsurge in preterm births all over the globe is evident due to certain risk factors such as infections, changes in lifestyle activities, increasing stress in pregnant women, and others. For instance, according to World Health Organization, approximately 15.0 million babies are born preterm every year across the world.

• According to World Health Organization (WHO) estimates, the preterm birth rate ranges from 5.0% to 18.0% among babies born across 184 countries.

The risk of further health complications has also increased due to the rising pre-term birth cases, of approximately 15.0 million patients every year. Many survivors face a lifetime of disabilities, including learning disabilities, visual & hearing problems, and breathing & feeding difficulties.

• According to an article published by National Organization for Rare Disorders (NORD), approximately 0.2 million infants are born each year prematurely in the U.S., and about 50,000 infants suffer from respiratory distress syndrome.

Thus, the increasing incidence of breathing disorders and invasive mechanical ventilation augments the adoption of devices for airway management in neonates. Moreover, the primary key companies across the globe are introducing these devices with advanced technologies for pediatric patients suffering from breathing disorders, further driving the market growth.

• According to an article published by Rapid Medtech Communications Ltd. in May 2021, globally, 415,000 neonates and infants require invasive mechanical ventilation per year and are intubated for greater than 24 hours. Moreover, approximately 75,000 neonates and infants experience at least one unplanned extubation.


• In May 2021, Medtronic plc announced the launch of the SonarMed airway monitoring system for pediatric patients in the U.S. The device is designed to check for any obstructions in the endotracheal tube and verify positions in real-time, helping clinicians to diagnose the neonatal more efficiently. Adopting the SonarMed airway monitoring system can help reduce the frequency of events such as intubation or extubation, which can help improve outcomes and reduce healthcare costs.

Therefore, the rising incidence of pre-term birth and all above mentioned key factors aids in the high adoption of such devices for treatment of neonatal patients worldwide, propelling the market growth.

AIRWAY MANAGEMENT DEVICES MARKET GROWTH FACTORS

Rising Number of Joint Ventures and Start-ups Amongst Industry Players will propel the Market

The demand for airway medical devices is increasing owing to the upsurge of the rising prevalence of chronic respiratory diseases requiring airway management across the globe. Thus, major industry players are actively focusing on producing technologically advanced airway devices and developing new R&D centers across the globe. Moreover, the rising production by key players and approval from regulatory bodies for low-cost devices is expected to boost the market growth.

• For instance, in April 2021, Medtronic launched the largest R&D center in India to launch new devices, advancing new technologies in surgical navigation and imaging, airway devices, ventilators, and many others.


• In August 2020, the FDA approved the use of LifeMech A-VS, a low-cost emergency resuscitator developed by LifeMech, Inc., that was designed to support the breathing management of patients during the COVID-19 pandemic.

Furthermore, various players are adopting strategies like joint ventures and start-ups to develop novel devices with expansive product portfolios for patients suffering from breathing disorders. Also, the rising focus of key players on developing technologically advanced devices in airway management to introduce a range of suitable products for both adults and neonates will boost the market during the forecast period.

• In January 2022, ICU Medical Inc., completed the acquisition of Smiths Medical from Smiths Group PLC, to increase the product portfolio globally in devices for airway management, vital care products, ambulatory infusion devices, and others to enhance the patient treatment experience and improve overall outcomes.

Therefore, such high investments by medical device manufacturers in R&D centers and for the production of devices are anticipated to fuel the introduction of advanced devices across various emerging nations, further propelling the airway management devices market growth.

RESTRAINING FACTORS

Complications Associated With the Use of Airway Devices to Limit the Adoption

The demand for effective treatment options to treat respiratory disorders is increasing globally. Intubation using airway management devices is often a life-saving procedure. Still, long-term use of these devices may pose short or long-term severe risks and potential complications such as regurgitation and aspiration of gastric contents, compression of vascular structures, trauma, and nerve injury. The incidence of such complications, including trauma and nerve injury, is comparatively low, but using some medical devices may carry significant risks.

• As per data published by BJA Education in 2019, an estimated 30.0% of patients with a temporary or permanent tracheostomy may have a significant complication relating to their surgery.

• According to an article published by IntechOpen, in September 2020, the Royal College of Anesthetists in the U.K. published data in the National Audit Project 4 (NAP4) report regarding major airway complications collected prospectively in approximately 3.0 million anesthetized patients throughout the U.K. The data stated that in full stomach conditions, aspiration by airway devices among all reported cases in NAP4 was 23.0% either as a primary or secondary event during their treatment.

Laryngeal mask airway devices can also pose a few complications in pediatric patients, including soft-tissue trauma, vomiting, regurgitation, stridor, and airway restriction on misplacement of the device. Also, potential long-term complications of using laryngeal mask airway devices, including laryngospasm, and venous and capillary congestion, are rising across the globe.

• According to an article by Cureus in April 2022, a trial was conducted on 106 randomized Anesthesia of American Society of Anaesthesiology patients using a laryngeal mask airway. The complications results were that about 6.6% had laryngospasm, 20.0% had airway obstruction, 15.0% had a cough, and 10.0% of patients had observed peripheral oxygen desaturation. The trial concluded that adverse respiratory events happen in awake and deep planes of anesthesia after removing the laryngeal mask airway device in children.

Thus, the rising number of severe risks and complications reported in patients by use these devices in are expected to hamper their extensive adoption, further restraining the market growth.

SEGMENTATION

By Type Analysis

To know how our report can help streamline your business, Speak to Analyst

Increasing Launch of Technologically Advanced Devices to Augment Segment Growth for Infraglottic Devices

The global market is segmented by type into infraglottic devices, supraglottic devices, laryngoscopes, andothers. Among types, the infraglottic devices segment accounted for the largest market share in 2021. The dominance was attributed to the rise in prevalence of chronic respiratory disorders globally, rising adoption of these devices by healthcare providers in intensive care units, and operating rooms for anesthetic and emergency procedures.

• For instance, according to an article published by BJA Education in 2019, more than 12,000 tracheostomy devices are inserted annually by physicians in the U.K., and up to 20.0% of patients in ICU are managed with a tracheostomy.

Moreover, the increasing focus of several key players on introducing technologically advanced devices and adding new widgets to their existing airway management product portfolio to provide enhanced patient care is primarily contributing to the segment's growth.

• In May 2021, Ambu A/S obtained U.S. FDA clearance for the Ambu VivaSight 2 DLT, the latest innovation in airway tubes for safe and cost-effective use by clinicians with a built-in camera used during single-lung ventilation procedures.


• In January 2020, Smiths Medical announced adding a PVC-based tracheostomy tube portfolio to its Portex Tracheostomy Tubes and Kits, designed to help clinicians provide the best patient care.

On the other hand, the supraglottic devices segment is expected to reach a comparatively higher CAGR during the forecast period. The segment's growth is attributed to increasing investments in production and the launch of single-use devices of airway management by key companies and high demand of these devices among healthcare professionals is likely contribute to the market growth in the region.

• In March 2020, Intersurgical Ltd introduced the newly advanced i-gel, a single-use supraglottic airway device used during spontaneous or intermittent positive pressure ventilation (IPPV) of the unconscious patient.

By Application Analysis

Increasing Number of Anesthesia Procedures will Augment the Segment Growth

Based on application, the market is segmented into anesthesia, emergency medicine, and others.

By application, the anesthesia segment accounted for the highest airway management devices market share in 2021. The highest share was attributable to rising global anesthetic procedures and rising chronic disorders requiring anesthetic intervention among the population.

• In October 2019, according to an article published by Medicus Healthcare Solutions, LLC, approximately 40.0 million surgical procedures utilize an anesthetic each year, and anesthesiologists handle roughly 90.0% of those cases.


• According to an article published by Springer Nature in September 2020, 11.0% of the global burden of disease requires surgical care, anesthesia management, or both. Some studies have estimated this burden to be as high as 30.0%.

On the other hand, the emergency medicine segment is projected to register a comparatively higher CAGR owing to its rising emergency visits in hospitals & ambulatory surgical centers across developed countries and increasing prevalence of trauma and accidental injuries among the population.

• As per European Society of Emergency Medicine (ESEM) estimates published in July 2020, emergency department visit rate is 100-300 visits per 1,000 habitants per year in Europe. Moreover, as per similar estimates, 25.0% of the European population visit the emergency departments annually.

By End User Analysis

Surge in Surgical Procedures in Hospitals & Ambulatory Surgical Centers to Propel Growth

Based on end-user, the market is segmented into hospitals & ambulatory surgical centers, homecare, and others.

Hospitals & ambulatory surgical centers segment accounted for the highest market share in 2021. The highest share was attributed to the rising number of hospitals, especially in emerging countries. An upsurge in surgical and aesthetical procedures with airway management interventions used for ventilation, oxygenation, and providing breathing support to patients is likely to contribute to the segment's growth.

• For instance, as per data revealed by the PAN American Health Organization (PAHO), 75.0% of hospitalized patients require breathing assistance during their treatment procedures.


• According to a report published by JAMA Network, approximately 189,000 patients undergo ambulatory laryngopharyngeal surgeries every year.

The homecare segment is expected to grow at a considerable CAGR during the forecast period. The growth is attributable to the rising number of the global geriatric population with chronic conditions across globe and high adoption of homecare settings amongst the geriatric population.

• According to an article published by Definitive healthcare in 2021, before the pandemic, 5.0 million people in 2019 received care at home in the U.S. However, post-COVID-19 pandemic, this number increased to 12.0 million by the end of 2020.

REGIONAL INSIGHTS

To get more information on the regional analysis of this market, Request a Free sample

Rise in Introduction of Technologically Advanced Airway devices to Augment North America Market

Based on region, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The North American market was valued at USD 0.87 billion in 2021 and is anticipated to continue to dominate the global market during the forecast period. The rising R&D and introduction of new technologies in devices of airway management by key players to help aid in patient treatment is likely to drive the North America market growth. Moreover, increasing collaborations among manufacturing players and rising approvals of new airway devices with extensive presence across the region further boosted the North American market.

• For instance, in May 2021, Olympus Corporation announced the FDA clearance of its Airway Mobilescopes, the MAF-TM2, MAF-GM2, and MAF-DM2, enabling providers to perform a variety of upper and lower airway management procedures.

Europe is the second most dominated region in terms of revenue and market share. The European market held a significant share due to the increasing number of emergency hospital visits and inpatient admissions in hospitals owing to the high prevalence of chronic disorders among the population. Similarly, increased demand for these devices for the treatment of such a high number of disorders will further propel the market growth in Europe.

• According to an article published by the Interactive Health Atlas of Lung conditions in England (INHALE), in February 2022, the emergency hospital admissions rate in England for respiratory disease has steadily and significantly increased, from the financial year 2014, with a rate of 1,228.0 per 0.1 million of the population to a rate of 1,592.0 per 0.1 million in the financial year 2020.

The market share in Asia Pacific region is driven by the rising prevalence of respiratory disorders amongst the Asia Pacific population, and the increasing demand for emergency care owing to high disease prevalence is anticipated for the region's growth at the highest CAGR.

• According to an article published by NCBI in July 2021, the prevalence of COPD in Asia Pacific countries is estimated at 14.5% in Australia, 16.7% in China, and 8.6% in Japan.

To know how our report can help streamline your business, Speak to Analyst

On the other side, the Latin American market is likely to grow slower. The growth in the region is owing to rising anesthetic procedures amongst the population and high demand for devices of airway management across hospitals and homecare settings. The Middle East & Africa region is expected to grow at a moderate CAGR owing to the rising number of hospitals and homecare centers providing treatment in the region, creating demand for airway devices during the forecast period.

KEY INDUSTRY PLAYERS

Robust Investments for New R&D Centers by Key Players to Propel Market Growth

The airway management devices industry is primarily dominated by manufacturers such as Smiths Medical (ICU Medical), Teleflex Incorporated, and other prominent players. The top market players are focusing on accelerating investments in medical device production centers and rising collaborations & acquisitions owing to the high demand for these devices across the globe. These factors are anticipated to augment the airway devices market growth.

• In May 2021, Teleflex Incorporated and Medline Industries, Inc. signed a definitive agreement to acquire Teleflex Incorporated’s non-invasive ventilation products (ventilation support through the patient's upper airway using a mask or similar device) and others that will further boost the company’s financial flexibility for its growth strategy.

Similarly, other prominent players in the market, including Ambu A/S, and Convatec plc, are continuously engaged in key developments, such as enhancing their distribution channel across the global market through strategic partnerships and extensive product approvals across the globe. Such initiatives by key players are projected to propel the global market and register growth by 2029.

• In May 2021, Ambu A/S obtained U.S. FDA clearance for the Ambu VivaSight 2 DLT, the latest innovation in airwsay tubes for safe and cost-effective use by clinicians with a built-in camera used during single-lung ventilation procedures.

Thus, such continuous engagement in the production of medical devices by several market players and a rising focus on enhancing their distribution channel across the global market through R&D investments in order to establish their footprints in emerging nations will further propel the market.

LIST OF KEY COMPANIES PROFILED IN AIRWAY MANAGEMENT DEVICES MARKET:

• Medtronic (Ireland)


• Teleflex Incorporated (U.S.)


• KARL STORZ SE & Co. KG (Germany)


• ICU Medical (U.S.)


• Convatec Group PLC (U.K.)


• Ambu A/S (Denmark)


• Intersurgical Ltd (U.K.)


• VBM Medizintechnik GmbH (Germany)


• VYAIRE MEDICAL INC. (U.S.)


• Flexicare Medical Limited (U.K.)

KEY INDUSTRY DEVELOPMENTS:

• January 2022 - Intersurgical Ltd announced the acquisition of Pulmodyne, Inc., a U.S., and Malaysian-based manufacturer, complementing in providing high-quality innovative airway and respiratory products for use in prehospital, emergency care, critical care, and at home. The acquisition will further help to provide Intersurgical with an elaborative presence in the U.S. market and for increased sales of the Pulmodyne ranges through the extensive global Intersurgical Ltd network.


• May 2021 - Teleflex Incorporated and Medline Industries, Inc., signed a definitive agreement to acquire Teleflex Incorporated non-invasive ventilation products (ventilation support through the patient's upper airway using a mask or similar device) and others that will further boost the company’s financial flexibility for its growth strategy.


• March 2021 - Convatec Group PLC announced the acquisition of Cure Medical, LLC bringing together the two innovative manufacturers of continence care products, to offer a more comprehensive range of products & services management of chronic conditions.


• December 2020 - Flexicare Medical Limited along with Medisize B.V., enhanced their presence in Europe region supported by the sales and distribution networks in European geographies including Netherlands, Czech Republic, and others in airway management and anesthesia devices.


• April 2020: Teleflex Incorporated announced significant production and expansion of the ISO-Gard Mask, a product that supports patients and clinicians when oxygen assistance is required. The expansion was in response to the increased demand by healthcare professional for treating patients globally with airway problems.

REPORT COVERAGE

An Infographic Representation of Airway Management Devices Market

View Full Infographic

To get information on various segments, share your queries with us

The airway management devices market report provides detailed market analysis and focuses on crucial aspects such as leading players, product types, and major indications of the product. Additionally, it offers insights into market trends, key industry developments such as mergers, partnerships, & acquisitions, and the impact of COVID-19 on the market. In addition to the factors mentioned above, the report includes the factors that have contributed to the market's growth in recent years with a regional analysis of different segments.

Report Scope & Segmentation